Johnson & Johnson has just released its Q2 figures showing sales fell back in the second quarter, a 3.5% growth …

Johnson & Johnson has named Alex Gorsky as its new chief executive, effective from 26 April. Gorsky was also nominated …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

